Cingulate CING
NASDAQ CING
$4.53 +0.17 (+3.90%)
At close: Oct 20, 2026 · 4:00 PM EDT

Cingulate (CING) Other Non-Current Assets (2022 - 2025)

Updated

Cingulate (CING) reported Other Non-Current Assets of $59,383 for Q4 2025.

Analysis

Cingulate (CING) Other Non-Current Assets (2022 - 2025) Analysis & Trends

Dating back to Q4 2022, Cingulate's Other Non-Current Assets record includes 5 quarters.

  • Other Non-Current Assets has a three-year compound annual growth rate of -16.0% (FY2022 to FY2025).
  • By year, Other Non-Current Assets came in at $178,780 in FY2023 (+78.2%) and $100,339 in FY2022.
  • The Q4 2025 figure ranks as the highest quarterly Other Non-Current Assets since Q2 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 14.27 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 10.73 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 4.75 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 9.94 Bn
10 Cingulate 59.73 Mn 4.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 59,383.00
Sep 30, 2024 13,763.00
Jun 30, 2024 69,449.00
Dec 31, 2023 178,780.00
Dec 31, 2022 100,339.00
API Access

Cingulate Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CING&period=max&api_key=YOUR_API_KEY